EUROCJD

         European Creutzfeldt Jakob Disease Surveillance Network
Home About the Network Surveillance Data CJD Images PROMISE study Publications Links

 

1994

  1. Alperovitch A, Brown P, Weber T, Pocchiari M, Hofman A, Will RG. Incidence of Creutzfeldt-Jakob disease in Europe 1993. Lancet 1994;343:918.

  2. Wientjens DPWM, Will RG, Hofman A. Creutzfeldt-Jakob disease:  a collaborative study in Europe . JNNP 1994;57:1285-99.

1995

  1. Delasnerie-Laupretre N, Poser S, Pocchiari M, Wientjens DPWM, Will RG. Creutzfeldt-Jakob disease in Europe. Lancet 1995;346:898.

1996

  1. Wientjens DPWM, Delasnerie-Laupretre N, Hofman A, Poser S, Pocchiari M, Will RG. Incidence of Creutzfeldt-Jakob disease in Europe. Neurology 1996;46:A290.

  2. Wientjens DPWM, Davanipour Z, Hofman A, Kondo K, Matthews WB, Will RG et al. Risk factors for Creutzfeldt-Jakob disease:  a reanalysis of case-control studies. Neurology 1996;46:1287-91.

  3. Will RG. Incidence of Creutzfeldt-Jakob disease in the European Community. In Gibbs CJJr, ed. Bovine Spongiform Encephalopathy:  The BSE Dilemma, pp 364-74. NY: Springer-Verlag, 1996.

  4. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A et al. A new variant of Creutzfeldt-Jakob disease in the UK . Lancet 1996;347:921-5.

1998

  1. Will RG, Alperovitch A, Poser S, Pocchiari M, Hofman A, Mitrova E et al. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. Ann Neurol 1998;43:763-7.

  2. van Duijn CM, Delasnerie-Laupretre N, Masullo C, Zerr I, De Silva R, Wientjens DPWM et al. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. Lancet 1998;351:1081-5.

  3. Will RG. Update on surveillance of Creutzfeldt-Jakob disease in Europe . In Office International des Epizooties, ed. Epidemiological studies and research on transmissible spongiform encephalopathies, pp 10-2. Paris: Office International des Epizooties, 1998.

1999

  1. Alperovitch A, Zerr I, Pocchiari M, Mitrova E, de Pedro Cuesta J, Hegyi I et al. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 1999;353:1673-4.

2000

  1. Zerr I, Brandel J-P, Masullo C, Wientjens D, De Silva R, Zeidler M et al. European surveillance on Creutzfeldt-Jakob disease:  a case-control study for medical risk factors. J Clin Epid 2000;53:747-54.

  2. Zerr I, Pocchiari M, Collins S, Brandel J-P, de Pedro Cuesta J, Knight RS et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.  Neurology 2000;55(6):811-5.

2001

  1. The EUROCJD Group.  Genetic epidemiology of Creutzfeldt-Jakob disease in Europe .  Rev Neurol (Paris) 2001; 157: 633-637.

2002

  1. Mitrova E, Belay G. Creutzfeldt-Jakob disease with E200K Mutation in Slovakia : Characterization and development. Acta Virologica 2002 46:31-39  

  2. Ward H, Everington D, Croes EA, Alperovitch A, Delasnerie-Laupretre N, Zerr I, Poser S, van Duijn CM. Sporadic Creutzfeldt-Jakob Disease and surgery: A case-control study using community controls. Neurology 2002; 59:543-548

  3. Alperovitch A, Will RG.  Predicting the size of the vCJD epidemic in France . C R Biologies 2002; 325:33-36

  4. van Everbroeck B, Green AJE, Vanmechelen E, Vanderstichele H, Pals P, Sanchez-Guerra M, Cuadrado Corrales N, Martin J-J, Cras P. Phosphorylated tau in cerebrospinal fluid as a marker for Creutzfeldt-Jakob disease. JNNP 2002;73:79-82

2003

  1. Brandel JP, Preece M, Brown P et al. Distribution of codon 129 genotype in human growth hormone-related CJD patients in France and the UK. Lancet 2003; 362:128-30

  2. Nurmi MH, Bishop M, Strain L, Brett F, McGuigan C, Hutchison M et al. The normal population distribution of PRNP codon 129 polymorphism. Acta Neurol Scand 2003; 108:374-378

  3. Jarius C.*, Kovács GG.*, Belay G., Hainfellner JA., Mitrova E., Budka H. (2003) Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt-Jakob disease. Acta Neuropathol 105(5):449-454

2004

  1. Pocchiari M, Puopolo M, Croes EA, Gelpi E, Collins S, Lewis V, Sutcliffe T, Giulivi A, Delasnerie-Laupretre N, Brandel J-P, Alperovitch A, Zerr I, Poser S, Kretzschmar H, Ladogana A, Rietvald I, Mitrova E, Martinez-Martin P, Pedro-Cuesta J, Glatzel M, Aguzzi A, Cooper S, Mackenzie J, van Duijn CM, Will RG. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 2004 127 2348-2359.

  2. Kovács GG, Kalev O, Budka H. (2004) Contribution of neuropathology to the understanding of human prion disease. Folia Neuropathol Suppl. A. 35-42.

  3. Kovács GG, Lindeck-Pozza E, Chimelli L, Araújo AQC, Gabbai AA, Ströbel T, Glatzel M, Aguzzi A, Budka H.  Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle. Ann Neurol 2004; 55: 121-125.

2005

  1. Kovacs GG, Puopolo M, Ladogana A, Pochiari M, Budka H, van Duijn C, Collins SJ, Boyd A, Giulivi A, Coulthart M, Delasnerie-Laupretre N, Brandel JP, Zerr I, Kretzschmar H, de Pedro Cuesta J, Calero-Lara M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrova E.  Genetic Prion Disease:  the EUROCJD experience.  Hum Genet (2005); 118: 166-174.

  2. Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, Klug GM, Sutcliffe T, Giulivi A, Alperocitch A, Delasnerie-Laupretre N, Brandel JP, Poser S, Kretzschmar H, Rietveld I, Mitrova E, de Pedro Cuesta J, Martinez-Martin P, Glatzel M, Aguzzi A, Knight R, Ward H, Pocchiari M, van Duijn CM, Will RG, Zerr I.  Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia and Canada.  Neurology 2005; 64: 1586-1591.

2006

 

  1. Georgsson G, Tryggvason T, Jonasdottir AD, Gudmundsson S, Thorgeirsdottir S. Polymorphism of PRNP codons in the normal Icelandic population. Acta Neurol Scand 2006: 113: 419–425

  2. Saetta AA, Michalopoulos NV, Malamis G, Papanastasiou PI, Mazmanian N, Karlou M, Kouzoupis A, Korkolopoulou P, Patsouris E. Analysis of PRNP gene codon 129 polymorphism in the Greek population.  Eur J Epidemiol. 2006;21(3):211-5  

  3. Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, Pocchiari M, Almonti S, Cuadrado-Corrales N, de Pedro Cuesta J, Budka H, Gelpi E, Glatzel M, Tolnay M, Hewer E, Zerr I, Heinemenn U, Kretzschmar HA, Jansen GH, Olsen E, Mitrova E, Alperovitch A, Brandel J-P, Mackenzie J, Murray K, Will RG. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 2006 September 2006; 129: 2278-2287.  

  4. Boesenberg-Grosse C, Schulz-Schaeffer WJ, Bodemer M, Ciesielczyk B, Meissner B, Krasnianski A, Bartl M, Heinemann U, Varges D, Eigenbrod S, Kretzschmar HA, Green A, Zerr I.  Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD?  BMC Neurology 2006; September; 1471-2377-6-35.

  5. Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Sanchez-Valle R, Mitrova E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Bodemer M, Slivarichova D, Saiz A, Calero M, Ingrosso L, Knight R, Janssens A C J W, van Duijn C M, Zerr I.  CSF tests in the differential diagnosis of Creutzfeldt-Jakob Disease.  Neurology 2006; 67; 637-643.

2007

  1. Green A, Sanchez-Juan P, Ladogana A, Cuadrado-Corrales N, Sanchez-Valle R, Mitrova E, Stoeck K, Sklaviadis T, Kulczycki J, Heinemann U, Hess K, Slivarichova D, Saiz A, Calero M, Mellina V, Knight R, van Duijn C M, Zerr I.  CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies.  European Journal of Neurology 2007;  14:  121-124

  2. Sanchez-Juan P, Sanchez-Valle R, Green A, Ladogana A, Cuadrado-Corrales N, Mitrova E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Krasnianski A, Equestre M, Slivarichova D, Saiz A, Calero M, Pocchiari M, Knight R, van Duijn C M, Zerr I.  Influence on timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis.  J Neurol 2007;  254:901-906

  3. Sanchez-Juan P, Houben MPWA, Hoff JI, Jansen C, Sie MPS, van Rujn MJE, Ironside JW, Will RG, van Duijn CM, Rozemuller A. The first case of variant Creutzfeldt-Jakob disease in the Netherlands . J Neurol 2007; 254: 958-960

  4. The European surveillance system for Creutzfeldt-Jakob disease, Prof RG Will, Dr RSG Knight, CJD Support Network Newsletter, March 2007, Issue 16.

  5. Sanchez-Juan P, Cousens SN, Will RG, van Duijn CM.  Source of variant Creutzfeldt-Jakob disease outside the United Kingdome.  Emerging Infectious Diseases 2007; 13(8): 1166-1169.

  6. Sanchez-Juan P, Bishop MT, Green A, Giannattasio C, Arias-Vasquez A, Poleggi A, Knight RSG and van Duijn CM. No evidence for association between tau gene haplotypic variants and susceptibility to Creutzfeldt-Jakob disease. BMC Medical Genetics 2007, 8:77

  7. McHugh JC, Bradley D, Hutchinson M, Brett F, Heffernan J, Howley R, Farrell M, Tubridy N. Variant Creutzfeldt-Jakob disease: first two indigenous cases in Republic of Ireland. Case report and perspective. Eur J Neurol. 2007 Apr;14(4):467-9.

  8. Matěj R, Rusina R, Koukolík F.  5 let činnosti Národní referenční laboratoře lidských prionových onemocnění při Oddělení patologie a molekulární medicíny FTNsP: naše zkušenosti a 0.přehled literatury. Cesk Slov Neurol N 2007; 70/103(6): 637-642

2008

  1. Georgsson G, Ólafsson E, Guđmundsson G.  Scrapie of sheep and Creutzfeldt-Jakob disease in Iceland . The Icelandic Medical Journal 2008 94: 541-548  

  2. Papacostas S, Malikides A, Petsa M, Kyriakides T.  Ten-year mortliaty from Creutzfeldt-Jakob disease in Cyprus.  Eastern Mediterranean Health Journal 2008; 14(3): 715-719.

  3. Pocchiari M, Ladogana A, Graziano S, Puopolo M. Creutzfeldt-Jakob disease: hopes for therapy. Editorial European Journal of Neurology 2008, 15: 435–436

  4. Bishop MT, Ritchie DL, Will RG, Ironside JW, Head MW, Thomson V, Bruce M, Manson JC. No major change in vCJD agent strain after secondary transmission via blood bransfusion.  PLoS ONE August 2008, 3(8): 2878.

  5. Mahillo-Fernandez I, de Pedro Cuesta J, Bleda MJ, Cruz M, Molbak K, Laursen H, Falkenhorst G, Martinez-Martin P, Siden A.  Surgery and Risk of Sporadic Creutzfeldt - Jakob disease in Denmark and Sweden: Registry-Based Case-Control Studies
    Neuroepidemiology 2008 31:229-240 

  6. Miele G, Seegar H, Marino D, Eberhard R, Heikenwalder M, Stoeck K,  Basagni M, Knight R, Green A, Chianini F, Wuthrich R, Hock C, Zerr I, Aguzzi A.  Urinary alpha-1-antichymotrypsin: A biomarker of prion infection.  PLoS 2008;3 (12):1-9

  7. Mitrová,E., Janáková, A.: Psychiatrické príznaky pri CJch z pohľadu diferenciálnej diagnostiky.  Slovenský lekár, 2008, 1-2:10-14.

  8. Mitrová,E. : Súčasná situácia v diagnostike CJch v SR: vyskytol sa aj nvCJch? Neurológia,  2008; 2:86-89.

  9. Mitrová,E. : Nekonvenčný svet prionových chorôb: malá retrospektíva a perspektívy, alebo 2+1  Nobelové ceny.  (Unconventional world of prion diseases: some retrospectives and perspectives or 2 + 1 Nobel prizes.) Edit. Herba, 2008:1-157.

  10. Mitrová,E. :  Dynamika výskytu CJch na Slovensku v rokoch 1975-2008.   Epidemiol. Mikrobiol. Imunol., 2009, 58; 4:172-177.

2009

  1. Brandel J-P, Heath CA, Head MW, Levavasseur E, Knight R, Laplanche J-L, Langeveld JPM, Ironside JW, Hauw J-J, Mackenzie J, Alpérovitch A, Will RG, Haďk S. Variant Creutzfeldt-Jakob disease in France and the United Kingdom: Evidence for the same agent strain Annals of Neurology 2009 65 (3) 249-256

  2. Ladogana, A., Sanchez-Juan, P., Mitrová, E., Green, A., Cuadrado-Corrales, N., Sánchez-Valle, R., Koscova, S., Aguzzi, A., Sklaviadis, Th., Kulczycki,J., Gawinecka,  J., Saiz, A., Calero, M., van Duijn, CM., Pocchiari,  M., Knight, R., Zerr, I. Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies J Neurol 2009, 256:1620-1628 

  3. Kovacs GG, Sanchez-Juan P, Ströbel T, Schuur M, Poleggi A, Nocentini S, Giannattasio C, Belay G, Bishop M, Capellari S, Parchi P, Gelpi E, Gal A, Bakos A, Molnar MJ, Heinemann U, Zerr I, Knight RSG, Mitrova E, van Duijn C, Budka H: Cathepsin D (C224T) polymorphism in sporadic and genetic Creutzfeldt-Jakob disease. Alzheimer Disease & Associated Disorders 2009 Jun 30. [Epub ahead of print]

  4. Meissner B, Kallenberg K, Sanchez-Juan P, Collie D, Summers DM, Almonti S,  Collins SJ, Smith P,  Cras P, Jansen GH, Brandel JP, Coulthart, Roberts H, van Everbroeck B, Galanaud D, Mellina V, Will RG, Zerr I.  MRI lesion profiles in sporadic Creutzfeldt–Jakob disease.  Neurology 2009; 72:1994-2001

  5. Zerr, I., Kallenberg, K., Summers, DM., Romero, C., Taratuto, A., Heinemann, U.,  Breithaupt, M., Varges, D., Meissner, B., Ladogana, A., Schuur, M., Haik, S., Collins, SJ., Jansen, GH., Stokin, GB., Pimentel, J., Hewer, E., Collie, D., Smith, P., Roberts, H., Brandel, JP., van Duijn, C., Pocchiari, M., Begue, C., Cras, P., Will, RG., Sanchez-Juan, P.  Updated clinical diagnostic criteria for sporadic CJD. Brain, 2009: 132(Pt 10):2659-68  

  6. Meissner, B., Kallenberg, K., Ramljak, S., Krasnianski, A., Heinemann, U., Krebs, B., Budka, H., Barcic, A., Kretzschmar, H.A., Knauth, M., Schulz-Schaeffer, W.J., Zerr I. MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease. J Neurology, 2009 256(3):355-63

  7. Pocchiari, M., Poleggi, A., Principe, S., Graziano, S. & Cardone, F. (2009). Genomic and post-genomic analyses of human prion diseases. Genome Med 1,

  8. Parchi, P., Notari, S., Weber, P., Schimmel, H., Budka, H., Ferrer, I., Haik, S., Hauw, J. J., Head, M. W., Ironside, J. W., Limido, L., Rodriguez, A., Strobel, T., Tagliavini, F. & Kretzschmar, H. A. (2009). Inter-laboratory assessment of PrPSc typing in Creutzfeldt-Jakob disease: a Western blot study within the NeuroPrion Consortium. Brain Pathol 19, 384-391.

  9. Pocchiari, M. (2009). Prevalence of variant CJD in the UK . BMJ 338, b435.

  10. Sikorska, B., Liberski, P. P., Sobow, T., Budka, H. & Ironside, J. W. (2009). Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker disease. Neuropathol Appl Neurobiol 35, 46-59.

  11. Anja Colja Venturini, Maja Bresjanac, Tanja Vranac1, Simon Koren, Mojca Narat, Mara Popović and Vladka Жurin Šerbec. Anti-idiotypic antibodies: a new approach in prion research. BMC Immunology 2009, 10:16 doi:10.1186/1471-21.

  12. Brandel JP, Heath CA , Head MW, Levavasseur E, Knight R, Laplanche JL, Langeveld JP, Ironside JW, Hauw JJ, Mackenzie J, Alpérovitch A, Will RG, Haďk S. Variant Creutzfeldt-Jakob disease in France and the United Kingdom : Evidence for the same agent strain. Ann Neurol. 2009 Mar; 65(3):249-56

  13. Mara Popović  Humane prenosljive spongiformne encefalopatije in njihova epidemiologija. Evropski veterinarski teden 2009 v Sloveniji  65-70

In Press

Kovacs GG, Horvath S, Ströbel T, Puskas M, Bakos A, Summers DM, Will RG, Budka H: Genetic Creutzfeldt-Jakob disease mimicking variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiat (in press)

 Mara Popović.  Diagnostics of Prion Diseases (in Press)